168 related articles for article (PubMed ID: 38338778)
1. The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy.
Larrinaga G; Valdivia A; Arrieta-Aguirre I; Solano-Iturri JD; Ugalde-Olano A; Loizaga-Iriarte A; Santos-Martín A; Pérez-Fernández A; Angulo JC; López JI
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338778
[TBL] [Abstract][Full Text] [Related]
2. Clinical Implications of (Pro)renin Receptor (PRR) Expression in Renal Tumours.
Solano-Iturri JD; Echevarría E; Unda M; Loizaga-Iriarte A; Pérez-Fernández A; Angulo JC; López JI; Larrinaga G
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33578778
[TBL] [Abstract][Full Text] [Related]
3. Expression and Function of Mas-Related G Protein-Coupled Receptor D and Its Ligand Alamandine in Retina.
Zhu P; Verma A; Prasad T; Li Q
Mol Neurobiol; 2020 Jan; 57(1):513-527. PubMed ID: 31392515
[TBL] [Abstract][Full Text] [Related]
4. Alamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes.
Jesus ICG; Scalzo S; Alves F; Marques K; Rocha-Resende C; Bader M; Santos RAS; Guatimosim S
Am J Physiol Cell Physiol; 2018 Jun; 314(6):C702-C711. PubMed ID: 29443552
[TBL] [Abstract][Full Text] [Related]
5. Genetic deletion of the alamandine receptor MRGD leads to dilated cardiomyopathy in mice.
Oliveira AC; Melo MB; Motta-Santos D; Peluso AA; Souza-Neto F; da Silva RF; Almeida JFQ; Canta G; Reis AM; Goncalves G; Cerri G; Coutinho D; Guedes de Jesus IC; Guatimosim S; Linhares ND; Alenina N; Bader M; Campagnole-Santos MJ; Santos RAS
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H123-H133. PubMed ID: 30339496
[TBL] [Abstract][Full Text] [Related]
6. Phosphoproteomic studies of alamandine signaling in CHO-MrgD and human pancreatic carcinoma cells: An antiproliferative effect is unveiled.
da Silva FA; Rodrigues-Ribeiro L; Melo-Braga MN; Passos-Silva DG; Sampaio WO; Gorshkov V; Kjeldsen F; Verano-Braga T; Santos RAS
Proteomics; 2022 Sep; 22(17):e2100255. PubMed ID: 35652611
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma.
Rasti A; Abolhasani M; Zanjani LS; Asgari M; Mehrazma M; Madjd Z
J Cancer Res Clin Oncol; 2017 Jan; 143(1):95-104. PubMed ID: 27638770
[TBL] [Abstract][Full Text] [Related]
9. PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance.
Filipović J; Bosić M; Ćirović S; Životić M; Dunđerović D; Đorđević D; Živković-Perišić S; Lipkovski A; Marković-Lipkovski J
Diagn Pathol; 2019 Oct; 14(1):120. PubMed ID: 31655611
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.
Zhao Q; Caballero OL; Davis ID; Jonasch E; Tamboli P; Yung WK; Weinstein JN; ; Strausberg RL; Yao J
Clin Cancer Res; 2013 May; 19(9):2460-72. PubMed ID: 23444225
[TBL] [Abstract][Full Text] [Related]
11. Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma.
Ho TH; Kapur P; Joseph RW; Serie DJ; Eckel-Passow JE; Parasramka M; Cheville JC; Wu KJ; Frenkel E; Rakheja D; Stefanius K; Brugarolas J; Parker AS
Urol Oncol; 2015 Jan; 33(1):23.e9-23.e14. PubMed ID: 25465300
[TBL] [Abstract][Full Text] [Related]
12. Alamandine through MrgD receptor induces antidepressant-like effect in transgenic rats with low brain angiotensinogen.
Almeida-Santos AF; de Melo LA; Gonçalves SCA; Oliveira Amaral LB; Santos RAS; Campagnole-Santos MJ; Kangussu LM
Horm Behav; 2021 Jan; 127():104880. PubMed ID: 33129833
[TBL] [Abstract][Full Text] [Related]
13. A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy.
Büttner FA; Winter S; Stühler V; Rausch S; Hennenlotter J; Füssel S; Zastrow S; Meinhardt M; Toma M; Jerónimo C; Henrique R; Miranda-Gonçalves V; Kröger N; Ribback S; Hartmann A; Agaimy A; Stöhr C; Polifka I; Fend F; Scharpf M; Comperat E; Wasinger G; Moch H; Stenzl A; Gerlinger M; Bedke J; Schwab M; Schaeffeler E
Genome Med; 2022 Sep; 14(1):105. PubMed ID: 36109798
[TBL] [Abstract][Full Text] [Related]
14. Brown adipose tissue transcriptome unveils an important role of the Beta-alanine/alamandine receptor, MrgD, in metabolism.
Cerri GC; Santos SHS; Bader M; Santos RAS
J Nutr Biochem; 2023 Apr; 114():109268. PubMed ID: 36641071
[TBL] [Abstract][Full Text] [Related]
15. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
[TBL] [Abstract][Full Text] [Related]
16. Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinoma.
Tschirdewahn S; Panic A; Püllen L; Harke NN; Hadaschik B; Riesz P; Horváth A; Szalontai J; Nyirády P; Baba HA; Reis H; Szarvas T
Int J Cancer; 2019 Jul; 145(2):531-539. PubMed ID: 30650187
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.
Rasti A; Madjd Z; Abolhasani M; Mehrazma M; Janani L; Saeednejad Zanjani L; Asgari M
Clin Exp Med; 2018 May; 18(2):177-190. PubMed ID: 29204790
[TBL] [Abstract][Full Text] [Related]
18. Alamandine and Its Receptor MrgD Pair Up to Join the Protective Arm of the Renin-Angiotensin System.
Schleifenbaum J
Front Med (Lausanne); 2019; 6():107. PubMed ID: 31245374
[TBL] [Abstract][Full Text] [Related]
19. Expression of parafibromin in major renal cell tumors.
Cui C; Lal P; Master S; Ma Y; Baradet T; Bing Z
Eur J Histochem; 2012 Oct; 56(4):e39. PubMed ID: 23361235
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinical value of SALL4 in renal cell carcinomas.
Che J; Wu P; Wang G; Yao X; Zheng J; Guo C
Mol Med Rep; 2020 Aug; 22(2):819-827. PubMed ID: 32468053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]